197 related articles for article (PubMed ID: 38304619)
1. Bisphosphonates do not affect healing of a critical-size defect in estrogen-deficient mice.
Strunz F; Gentil-Perret S; Siegrist M; Bohner M; Saulacic N; Hofstetter W
Bone Rep; 2024 Mar; 20():101739. PubMed ID: 38304619
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates reduce biomaterial turnover in healing of critical-size rat femoral defects.
Hauser M; Siegrist M; Denzer A; Saulacic N; Grosjean J; Bohner M; Hofstetter W
J Orthop Surg (Hong Kong); 2018; 26(3):2309499018802487. PubMed ID: 30270749
[TBL] [Abstract][Full Text] [Related]
3. The bone morphogenetic protein 2 analogue L51P enhances spinal fusion in combination with BMP2 in an in vivo rat tail model.
Gantenbein B; Oswald KAC; Erbach GF; Croft AS; Bermudez-Lekerika P; Strunz F; Bigdon SF; Albers CE
Acta Biomater; 2024 Mar; 177():148-156. PubMed ID: 38325708
[TBL] [Abstract][Full Text] [Related]
4. Healing of fractures in osteoporotic bones in mice treated with bisphosphonates - A transcriptome analysis.
Hauser M; Siegrist M; Keller I; Hofstetter W
Bone; 2018 Jul; 112():107-119. PubMed ID: 29680263
[TBL] [Abstract][Full Text] [Related]
5. The BMP2 antagonist inhibitor L51P enhances the osteogenic potential of BMP2 by simultaneous and delayed synergism.
Khattab HM; Ono M; Sonoyama W; Oida Y; Shinkawa S; Yoshioka Y; Maekawa K; Tabata Y; Sugama K; Sebald W; Kuboki T
Bone; 2014 Dec; 69():165-73. PubMed ID: 25240457
[TBL] [Abstract][Full Text] [Related]
6. L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin.
Albers CE; Hofstetter W; Sebald HJ; Sebald W; Siebenrock KA; Klenke FM
Bone; 2012 Sep; 51(3):401-6. PubMed ID: 22750402
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of endogenous antagonists with an engineered BMP-2 variant increases BMP-2 efficacy in rat femoral defect healing.
Sebald HJ; Klenke FM; Siegrist M; Albers CE; Sebald W; Hofstetter W
Acta Biomater; 2012 Oct; 8(10):3816-20. PubMed ID: 22750247
[TBL] [Abstract][Full Text] [Related]
8. Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: A drill-hole defect model.
He YX; Zhang G; Pan XH; Liu Z; Zheng LZ; Chan CW; Lee KM; Cao YP; Li G; Wei L; Hung LK; Leung KS; Qin L
Bone; 2011 Jun; 48(6):1388-400. PubMed ID: 21421090
[TBL] [Abstract][Full Text] [Related]
9. The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis model.
Takahata M; Ito M; Abe Y; Abumi K; Minami A
Bone; 2008 Dec; 43(6):1057-66. PubMed ID: 18835375
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats.
Cao Y; Mori S; Mashiba T; Westmore MS; Ma L; Sato M; Akiyama T; Shi L; Komatsubara S; Miyamoto K; Norimatsu H
J Bone Miner Res; 2002 Dec; 17(12):2237-46. PubMed ID: 12469918
[TBL] [Abstract][Full Text] [Related]
11. Effects of substitute coated with hyaluronic acid or poly-lactic acid on implant fixation: Experimental study in ovariectomized and glucocorticoid-treated sheep.
Andreasen CM; Ding M; Andersen TL; Overgaard S
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1122-e1130. PubMed ID: 28485126
[TBL] [Abstract][Full Text] [Related]
12. Triphasic calcium-based implant material resorbs and is replaced with bone in ovariectomized rats with or without bisphosphonate treatment.
Shaul J; Hill R; Bruder S; Tilton A; Howe J
J Orthop Res; 2022 Oct; 40(10):2271-2280. PubMed ID: 34935182
[TBL] [Abstract][Full Text] [Related]
13. Impact of Single or Combined Drug Therapy on Bone Regeneration in Healthy and Osteoporotic Rats.
Shaheen MY; Basudan AM; Niazy AA; van den Beucken JJJP; Jansen JA; Alghamdi HS
Tissue Eng Part A; 2021 May; 27(9-10):572-581. PubMed ID: 32838702
[TBL] [Abstract][Full Text] [Related]
14. Topical bisphosphonate augments fixation of bone-grafted hydroxyapatite coated implants, BMP-2 causes resorption-based decrease in bone.
Baas J; Vestermark M; Jensen T; Bechtold J; Soballe K; Jakobsen T
Bone; 2017 Apr; 97():76-82. PubMed ID: 28082076
[TBL] [Abstract][Full Text] [Related]
15. Healing of osteoporotic bone defects by baculovirus-engineered bone marrow-derived MSCs expressing MicroRNA sponges.
Li KC; Chang YH; Yeh CL; Hu YC
Biomaterials; 2016 Jan; 74():155-66. PubMed ID: 26454414
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats.
Chen B; Li Y; Yang X; Xu H; Xie D
Osteoporos Int; 2013 Jul; 24(7):2115-21. PubMed ID: 23389695
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with parathyroid hormone (1-34) and beta-tricalcium phosphate had an additive effect on local bone formation in a rat defect model.
Tao ZS; Tu KK; Huang ZL; Zhou Q; Sun T; Xu HM; Zhou YL; Lv YX; Cui W; Yang L
Med Biol Eng Comput; 2016 Sep; 54(9):1353-62. PubMed ID: 26429350
[TBL] [Abstract][Full Text] [Related]
18. Exogenous Stimulation of Human Intervertebral Disc Cells in 3-Dimensional Alginate Bead Culture With BMP2 and L51P: Cytocompatibility and Effects on Cell Phenotype.
May RD; Frauchiger DA; Albers CE; Hofstetter W; Gantenbein B
Neurospine; 2020 Mar; 17(1):77-87. PubMed ID: 32252157
[TBL] [Abstract][Full Text] [Related]
19. The fast degradation of β-TCP ceramics facilitates healing of bone defects by the combination of BMP-2 and Teriparatide.
Xie Z; Yan D; Zhou Q; Wu Z; Weng S; Boodhun V; Bai B; Shen Z; Tang J; Chen L; Wang B; Yang L
Biomed Pharmacother; 2019 Apr; 112():108578. PubMed ID: 30784943
[TBL] [Abstract][Full Text] [Related]
20. Biological Response to Recombinant Human Bone Morphogenetic Protein-2 on Bone-Implant Osseointegration in Ovariectomized Experimental Design.
Song Y; Wan L; Zhang S; Du Y
J Craniofac Surg; 2019 Jan; 30(1):141-144. PubMed ID: 30616310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
